Recent publications

Body:

List of VHPB publications online available

Many European countries 'flying blind' in their efforts to eliminate viral hepatitis.
Lazarus JV, Safreed-Harmon K, Colombo M, Reic T, Schatz E, Van Damme P; ACHIEVE Coalition.
Nat Rev Gastroenterol Hepatol. 2017 Jul 26;14(8):445-446. doi: 10.1038/nrgastro.2017.98.
Single-Dose Hepatitis A Immunization: 7.5-Year Observational Pilot Study in Nicaraguan Children to Assess Protective Effectiveness and Humoral Immune Memory Response.
Mayorga O, Bühler S, Jaeger VK, Bally S, Hatz C, Frösner G, Protzer U, Van Damme P, Egger M, Herzog C.

Recent newsletters

Body:

VHPB Newsletter

Highlighting underserved groups for screening, prevention and treatment of viral hepatitis B and C in Europe
Newsletter 1/2017 - September/2017  Ljubljana, Slovenia 883 kB (.pdf)
Prevention and control of viral hepatitis in the Baltic States: lessons learnt and the way forward
Newsletter 2/2016 - June/2016  Riga, Latvia 463 kB (.pdf)
Towards a hepatitis-free Europe: how to make it feasible and affordable
Newsletter 1/2016 - January/2016  London, United Kingdom 725 kB (.pdf)

News - Hepatitis C Elimination in Europe. European Policy Guidelines of the Hepatitis B and C Public Policy Association

In collaboration with VHPB and other leading experts in the field, the Hepatitis B&C Public Policy Association has developed concrete policy recommendations and actions to be taken at national level to implement the Elimination Manifesto and to contribute to the elimination of HCV by 2030.

Tags: 

News - Pediatric Vaccines and Vaccinations. A European Textbook.

This book aims to provide information on the current vaccines that are used in childhood immunizations programs in Europe and the principles which underlie them. The textbook is destined to “vaccinologists” and European and other pediatricians and practitioners who deal with vaccines and vaccinations and will hopefully be used in the curriculum.

Editors: Vesikari, Timo, Van Damme, Pierre (Eds.)

Tags: 

News - Action plan for the health sector response to viral hepatitis in the WHO European Region (2017)

WHO published the first Action plan for the health sector response to viral hepatitis in the WHO European Region (2017). The action plan adapts the Global Health Sector Strategy on Viral Hepatitis, 2016–2021 to the context of the European Region. The document addresses all five hepatitis viruses, but its major focus is on hepatitis B and C, given the high public health burden they represent in the Region. 

Tags: 

News - Meeting of the International Task Force for Disease Eradication, June 2017

The meeting report of the International Task Force for Disease Eradication to discuss viral hepatitis elimination was published in the September 15th issue of the WHO weekly epidemiological record (WER). The report details:

  • information presented and discussed at the meeting 
  • ITFDE endorsement of the WHO elimination goals for hepatitis B and hepatitis C
  • ITFDE recommendations for activities (underway and new actionable ideas) to accelerate progress toward viral hepatitis elimination
Tags: 

News - Prevention as an essential part of elimination: Norway and the United Kingdom have recently become the latest countries in the WHO European Region to add hepatitis B vaccination to their routine immunization schedules

Eliminating the threat of HBV infection requires a comprehensive approach that includes prevention of infections acquired immediately before and after birth and during childhood, as well as during adolescence and adulthood. Norway and the United Kingdom have recently become the latest countries in the WHO European Region to add hepatitis B vaccination to their routine immunization schedules: Norway has offered the vaccine since February 2017 and the United Kingdom will provide a hexavalent vaccine, including hepatitis B, at age 2 months for children born after 1 August 2017. With these two additional countries offering population-wide protection against the virus, the Region is one step closer to its goal of controlling HBV infection, as established in the European Vaccine Action Plan 2015–2020. More info

Tags: 

Older news items can be found in the news archive.